Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.Semaglutide improved how much the heart’s upper left chamber stretched by 5.7 percentage points versus placebo over 52 weeks in a 49-person trial substudy.
An observational study of adults assessed at average ages 57 and 75 linked two anti-inflammatory blood proteins to later heart failure hospitalizations.An observational study of adults assessed at average ages 57 and 75 linked two anti-inflammatory blood proteins to later heart failure hospitalizations.
Participants in the highest fifth for an inflammation marker had a 43% higher relative risk of major cardiovascular events than those in the lowest fifth.Participants in the highest fifth for an inflammation marker had a 43% higher relative risk of major cardiovascular events than those in the lowest fifth.
Higher values were linked to lower stroke risk (hazard ratio 0.81) but higher heart failure risk (1.28) over a median 4.4 years.Higher values were linked to lower stroke risk (hazard ratio 0.81) but higher heart failure risk (1.28) over a median 4.4 years.
In an observational study of 33,258 UK adults, an automated measure of heart muscle strain was linked to death, heart failure, and stroke.In an observational study of 33,258 UK adults, an automated measure of heart muscle strain was linked to death, heart failure, and stroke.
A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.A rising heart volume index carried a hazard ratio of 1.41 for preserved-ejection heart failure against 1.18 for heart failure with reduced ejection.
Over 36 weeks, empagliflozin reduced the heart’s main pumping chamber’s volume after contraction by 6.0 milliliters per square meter of body surface area versus placebo.Over 36 weeks, empagliflozin reduced the heart’s main pumping chamber’s volume after contraction by 6.0 milliliters per square meter of body surface area versus placebo.
A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.A heart-relaxation measure stayed at 6.2 with dapagliflozin, versus 6.6 to 6.7 with placebo, in a 32-person randomized trial.
In 59,416 UK Biobank participants, peak early diastolic longitudinal strain rate showed the strongest association with incident heart failure, with a hazard ratio of…In 59,416 UK Biobank participants, peak early diastolic longitudinal strain rate showed the strongest association with incident heart failure, with a hazard ratio of 0.55.